Results 151 to 160 of about 6,033 (178)
Some of the next articles are maybe not open access.

Renal sympathetic denervation: hypertension therapy and beyond

Expert Review of Medical Devices, 2013
Hypertension is one of the most important treatable causes of mortality and morbidity in the world, but despite the wide availability of pharamacological therapy, blood pressure is poorly controlled in many patients. Renal sympathetic denervation (RSD) is a novel therapeutic option whereby the renal sympathetic nerves, which lie within and around the ...
Paul D, Williams, Rob, Whitbourn
openaire   +2 more sources

Copeptin, resistant hypertension and renal sympathetic denervation

Biomarkers, 2016
Renal denervation is used as a treatment option for patients with resistant hypertension. But only a subgroup of patients benefits from renal sympathetic denervation (RDN). Biomarkers might be helpful to identify patients who respond to RDN. Copeptin as a surrogate for vasopressin levels is increased in hypertension and other cardiovascular diseases ...
Marius, Schwerg   +3 more
openaire   +2 more sources

Renal sympathetic denervation: applications in hypertension and beyond

Nature Reviews Cardiology, 2013
Renal afferent and efferent sympathetic nerves are involved in the regulation of blood pressure and have a pathophysiological role in hypertension. Renal sympathetic denervation is a novel therapeutic technique for the treatment of patients with resistant hypertension.
Michael, Böhm   +4 more
openaire   +2 more sources

Role of Renal Sympathetic Denervation in Hypertension

Future Cardiology, 2020
Noman Lateef   +10 more
openaire   +2 more sources

Renal nerve stimulation: complete versus incomplete renal sympathetic denervation

Blood Pressure, 2021
Annemiek F Hoogerwaard   +2 more
exaly  

Renal sympathetic denervation in Sweden

Journal of Hypertension, 2019
Yazan, Sawalha   +4 more
openaire   +2 more sources

Renal Sympathetic Denervation

2018
Jacob S. Koruth   +2 more
openaire   +1 more source

Quantification of Renal Sympathetic Vasomotion as a Novel End Point for Renal Denervation

Hypertension, 2020
Peter Ricci Pellegrino   +2 more
exaly  

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension

Circulation, 2012
Murray Esler   +2 more
exaly  

Home - About - Disclaimer - Privacy